Susquehanna Portfolio Strategies, LLC Halozyme Therapeutics, Inc. Transaction History
Susquehanna Portfolio Strategies, LLC
- $4.58 Trillion
- Q2 2025
A detailed history of Susquehanna Portfolio Strategies, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna Portfolio Strategies, LLC holds 188,100 shares of HALO stock, worth $13.2 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
188,100Holding current value
$13.2 Million% of portfolio
0.21%Shares
1 transactions
Others Institutions Holding HALO
# of Institutions
645Shares Held
124MCall Options Held
408KPut Options Held
384K-
Black Rock Inc. New York, NY17.6MShares$1.24 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.6MShares$816 Million0.01% of portfolio
-
State Street Corp Boston, MA5.94MShares$416 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.47MShares$243 Million0.03% of portfolio
-
Snyder Capital Management L P San Francisco, CA2.73MShares$192 Million3.97% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $9.77B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...